The end of blockbusters is not upon us, despite what some analysts are saying. In fact, we expect that blockbusters will continue to be an important part of pharmaceutical market growth over the next five years, due to new uses for existing therapies, the emergence of niche/specialty products, and the ongoing demand for chronic disease treatments. |
This is where the growth is going to come from for the next five years, 10 years, 20 years and more. |